Serum levels of circulating intercellular adhesion molecule-1 in patients with breast cancer

Anticancer Research

Volumn 17, Issue 4 A, 1997, Pages 2823-2826

  Sheen Chen, Shyr Ming ^a   Eng, Hock Liew ^a   Sheen, Chih Wei ^a   Cheng, Yu Fan ^a   Chou, Fong Fu ^a   Chen, Wei Jen ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Breast cancer; Intercellular adhesion molecule 1; Serum

Indexed keywords

ESTROGEN RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; AGE; AGED; ARTICLE; BLOOD LEVEL; BREAST CANCER; BREAST CARCINOMA; CANCER STAGING; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME; VENOUS BLOOD;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MIDDLE AGED; PROGNOSIS; REGRESSION ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030856954     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Springer TA: Adhesion receptors of the immune system. Nature 346: 425-434, 1990.
2. Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA' Primary structure of intercellular adhesion molecule-1 (ICAM-1) demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 52: 925-933, 1988.
3. Diamond MS, Staunton DE, DeFougerolles AR, Stacker SA, GarciaAguilar J, Hibbs ML et al: ICAM-1 (CD54): A counter-receptor for Mac-1 (CD11b/CD18). J Cell Biol 111: 3129-3139, 1990.
4. Makgoba MW, Sanders ME, Luce GEG, Gugel EA, Dustin ML, Springer TA et al: Functional evidence that ICAM- 1 is a ligand for LFA- 1 in cytotoxic T cell recognition. Eur J Immunol 18: 637-640, 1988.
5. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer Ta. Induction by IL-1 and Interferon-γ: Tissue distribution, biochemistry and function of a natural adherence molecale (ICAM-1). J Immunol 137: 245-254, 1986.
6. Larson RS, Spinger TA. Structure and function of leukocyte integrins. Immunol Rev 114: 181-217, 1990.
7. Rothlein R, Czajkowski M, O'neill MM, Marlin SD, Mainolfi E, Merluzzi VJ. Induction, of intercellular adhesion molecule-1 on primary and continuous cell lines by pro-inflammatory cytokines. J Immunol 141: 1665-1669, 1988.
8. Vejlsgaard GL, Ralfkiaer E, Avnstorp C, Czajkowski M, Mariin SD, Rothlein R. Kinetics and characteristics of intercellular adhesion molecule- 1 (ICAM-1) expression on keratinocytes in various inflammatory skin lesions and malignant cutaneous lymphomas. J Am Acad Dermatol 20: 782-790, 1989.
9. Adams DH, Hubscher SG, Shaw J, Rothiein R, Neubergen JM. Intercellular adhesion molecule-1 on liver allografts during rejection. Lancet 2: 1122-1124, 1989.
10. Adams DH, Hubscher SG, Shaw J, Johnson GD, Babbs C, Rothlein R, Neuberger JM. Increased expression of intercellular adhesion molecule! on bile duct in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 14: 426-431, 1991.
11. Volpes R, Van den Oord JJ, Desmet VJ. Immunohistochemical study of adhesion molecule in liver inflammation. Hepatology 12: 59-65, 1990.
12. Qckenhouse CF, Betager R, Springer TA, Staunton D. Plasmodium folciparum-infected erythrocytes bind ICAM-1 at a site distinct from LAF-1, Mac-1 and human Rhinovirus. Cell 68: 63-69, 1992.
13. Marlin SD, Staunton DE, Springer TA, Stratowa C, Sommergruber W, Merluzzi VJ. A soluble form of intercellular adheison molecule-1 inhibits Rhinovirus infection. Nature 344: 70-72, 1990.
14. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol 147: 3788-3793, 1991.
15. Seth R, Raymond FD, Makgoba MW. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet 338: 83-84, 1991.
16. Tsujisaki M, Imai I, Hirata H, Hanzawa Y, Masuya J, Nakano T et al: Detection of circulating intercellular adhesion molecule- 1 antigen in malignant disease. Clin Exp Immunol 85: 3-8, 1991.
17. Harning R, Mainolfi E, Bystryn JC, Henn M, Merluzzi VJ, Rothlein R: Serum levels of circulating intercellular adhesion molecule-1 in human malignant melanoma. Cancer Res 51: 5003-5005, 1991.
18. Natali P, Nicotra MR, Cavaliere R, Bigotti A, Romano G, Temponi M, Ferrone S: Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. Cancer Res 50: 1275-1278, 1990.
19. Sheen-Chen SM, Chou FF, Eng HL, Chen WJ: An evaluation of the prognostic significance of HLA-DR expression in axillary-node-negative breast cancer. Surgery 116: 510-515, 1994.
20. NIH Consensus Conference: Treatment of early stage breast cancer. JAMA 265: 391-395, 1991.
21. Staging for carcinoma of the breast. Beahrs O, Henson D, Hutter R, Myers M, eds. In manual for staging of cancer: 3rd ed Philadelphia: JB Lippincott, 1988 pp 145-150
22. Liang JT, Wang CR, Chang KJ, Chuang CY: Circulating intercellular adhesion molecule-1 and lymphocyte subsets involved in immune response of breast cancer. Chinese J Microbiol Immunol 26: 1-5, 1993.
23. McGuire WL, Clark GM: Prognostic factors and treatment decision in axillary-node-negative breast cancer. N Engl J Med 326: 1756-1761, 1992.